Dapagliflozin: all 489 studies that test it

Page 3 of 5. Open to participants first (118), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesCompletedNCT01606007Phase 3Results posted
• PK Study of Dapagliflozin in Pediatric Subjects With T2DMCompletedNCT01525238Phase 1Results posted
• BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 DiabetesCompletedNCT01498185Phase 2Results posted
• Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/ActionCompletedNCT01439854Not applicableResults posted
• Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaCompletedNCT01392677Phase 3Results posted
• Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT01294436Phase 3Results posted
• Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT01294423Phase 3Results posted
• Evaluation of Dapagliflozin Taken Twice-dailyCompletedNCT01217892Phase 3Results posted
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationCompletedNCT01195662Phase 3Results posted
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerCompletedNCT01137474Phase 3Results posted
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCompletedNCT01095666Phase 3Results posted
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseCompletedNCT01095653Phase 3Results posted
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseCompletedNCT01042977Phase 3Results posted
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionCompletedNCT01031680Phase 3Results posted
• Dapagliflozin DPPIV Inhibitor add-on StudyCompletedNCT00984867Phase 3Results posted
• Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesCompletedNCT00976495Phase 2Results posted
• Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT00972244Phase 2Results posted
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesCompletedNCT00859898Phase 3Results posted
• Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 DiabetesCompletedNCT00855166Phase 3Results posted
• Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 DiabetesCompletedNCT00831779Phase 2Results posted
• Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesCompletedNCT00736879Phase 3Results posted
• Add-on to Thiazolidinedione (TZD) FailuresCompletedNCT00683878Phase 3Results posted
• Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsCompletedNCT00680745Phase 3Results posted
• Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinCompletedNCT00673231Phase 3Results posted
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentCompletedNCT00663260Phase 2/3Results posted
• Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsCompletedNCT00660907Phase 3Results posted
• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsCompletedNCT00643851Phase 3Results posted
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCompletedNCT00528879Phase 3Results posted
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseCompletedNCT00528372Phase 3Results posted
• A Pilot Study of BMS-512148 in Subjects With Type 2 DiabetesCompletedNCT00357370Phase 2/3Results posted
• Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT07881796Not applicable
• Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinCompletedNCT07754331Phase 1
• Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus NephritisActive, not recruitingNCT07678203Phase 1/2
• Dapagliflozin in Living-Donor Kidney Transplant RecipientsActive, not recruitingNCT07555106Phase 2
• A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without FoodCompletedNCT07404137Phase 1
• A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.CompletedNCT07363707Phase 4
• SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and AnemiaCompletedNCT07344922Phase 3
• Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver DiseaseCompletedNCT07338331Not applicable
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.Active, not recruitingNCT07222917Phase 2
• The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and ObesityCompletedNCT07120828Phase 4
• Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk FactorsCompletedNCT07077525Phase 4
• The Effect of Dapagliflozin on Patients With CardiomyopathyCompletedNCT07076615Phase 4
• Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled CancersActive, not recruitingNCT07033585Phase 2/3
• Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).Active, not recruitingNCT07020377Phase 1/2
• A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.CompletedNCT06979388Phase 1
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High ProteinuriaActive, not recruitingNCT06942910Phase 2
• Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard TreatmentCompletedNCT06915870Not applicable
• Dapagliflozin to Prevent Anthracycline-Induced CardiotoxicityCompletedNCT06888505Phase 2
• Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedNCT06851962Phase 4
• Effects of Sodium-Glucose Co-transporter 2 Inhibitors on InflammationCompletedNCT06812429Early Phase 1
• Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of LifeCompletedNCT06759077Phase 3
• Dapagliflozin as Prophylaxis for Glucocorticoid-Induced HyperglycemiaActive, not recruitingNCT06748105Phase 2
• Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG StudyCompletedNCT06721442Phase 4
• The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.CompletedNCT06719661Not applicable
• Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep ApneaCompletedNCT06690723Phase 3
• A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese ParticipantsCompletedNCT06651021Phase 1
• Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial InfarctionStatus unknownNCT06619600Phase 3
• Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients with Acute Myocardial InfarctionCompletedNCT06615674Phase 4
• A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney DiseaseActive, not recruitingNCT06610526Phase 4
• Effect of the Use of Dapagliflozin in Patients With Refractory Heart FailureActive, not recruitingNCT06578520Phase 4
• Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 DiabetesActive, not recruitingNCT06532682Phase 4
• Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial FibrillationCompletedNCT06433479Not applicable
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed ConditionsCompletedNCT06399068Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting ConditionsCompletedNCT06399055Phase 1
• Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.CompletedNCT06383832Phase 4
• Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.CompletedNCT06374043Phase 4
• MASLD in Primary Hypothyroidism and Efficacy of DapaglifozinActive, not recruitingNCT06373523Early Phase 1
• Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic PatientsCompletedNCT06326034Phase 4
• Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)Active, not recruitingNCT06317051Phase 3
• A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.Active, not recruitingNCT06268873Phase 3
• Bioequivalence Study of Dapagliflozin 10 mg Film-coated TabletsCompletedNCT06127212Not applicable
• Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility StudyCompletedNCT06111768Phase 2
• Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial FibrillationActive, not recruitingNCT06111443Phase 2/3
• Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)Active, not recruitingNCT06087835Phase 3
• Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF PatientsCompletedNCT06065280Not applicable
• A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.CompletedNCT06063109Phase 1
• Clinical Value of Adding Dapagliflozin in Patients With Nephrotic SyndromeCompletedNCT06026787Phase 4
• Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)CompletedNCT06012279Phase 4
• The Effect of Dapagliflozin on Weight Loss in Obese Adults Without DiabetesActive, not recruitingNCT06000462Phase 4
• GLUcose Transport and REnalPROtection in Chronic Kidney DiseaseCompletedNCT05998837Phase 2/3
• Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by CardiotomographyCompletedNCT05998525Phase 3
• Dapagliflozin in Patients With Ulcerative ColitisCompletedNCT05986136Phase 2/3
• A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.CompletedNCT05884866Phase 2
• Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle DysfunctionCompletedNCT05849766Phase 3
• Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.Status unknownNCT05849220Not applicable
• Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin TherapyCompletedNCT05797935Phase 4
• Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid CardiomyopathyCompletedNCT05795400Not applicable
• Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive DisordersCompletedNCT05792540Phase 2
• Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?Active, not recruitingNCT05788276Phase 4
• Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot StudyActive, not recruitingNCT05782972Phase 4
• The Fontan Dapagliflozin Pilot StudyCompletedNCT05741658Phase 4
• Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease PatientsCompletedNCT05735197Phase 4
• Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseaseActive, not recruitingNCT05719714Phase 1/2
• Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE)Status unknownNCT05717257Phase 4
• Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease PatientsStatus unknownNCT05710367Phase 2
• SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis PatientsCompletedNCT05704088Phase 4
• SGLT2 Inhibitor for Severe Tricuspid RegurgitationStatus unknownNCT05686616Not applicable
• Dapagliflozin With or Without Spironolactone for HFpEFCompletedNCT05676684Phase 2/3
• Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting ConditionCompletedNCT05673369Phase 1
• Dapagliflozin Therapy In Cardiac SurgeryCompletedNCT05621551Phase 4

← Dapagliflozin overview